AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.12), $0.24 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $69.7 million versus the consensus estimate of $67.1 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.